Alzheimer’s Amyloid-Beta and Tau Proteins Act as Prions, New Analysis Finds


Prions are misfolded variations of a protein that may unfold like an an infection by forcing regular copies of that protein into the identical self-propagating, misfolded form. In line with new analysis led by the College of California, San Francisco (UCSF), Alzheimer’s illness is a double-prion dysfunction by which amyloid beta and tau proteins collectively destroy the mind. Utilizing novel lab assessments, UCSF researchers Stanley Prusiner and Carlo Condello and their colleagues had been in a position to detect and measure particular, self-propagating prion types of amyloid beta and tau proteins in mind tissue of 75 Alzheimer’s sufferers.

The normal form of amyloid beta has been tagged with a yellow marker in these cells, making healthy cells a uniform pale yellow (left). Contact with prion forms of amyloid beta -- for example in extracts from human brain tissue -- forces these yellow proteins into the sticky prion form as well, leading to the formation of bright yellow clumps (right). Image credit: Prusiner Lab / UCSF Institute for Neurodegenerative Diseases.

The conventional type of amyloid beta has been tagged with a yellow marker in these cells, making wholesome cells a uniform pale yellow (left). Contact with prion types of amyloid beta — for instance in extracts from human mind tissue — forces these yellow proteins into the sticky prion type as properly, resulting in the formation of vivid yellow clumps (proper). Picture credit score: Prusiner Lab / UCSF Institute for Neurodegenerative Illnesses.

“I imagine this exhibits past a shadow of a doubt that amyloid beta and tau are each prions, and that Alzheimer’s illness is a double-prion dysfunction,” Dr. Prusiner mentioned.

“The truth that prion ranges additionally seem linked to affected person longevity ought to change how we take into consideration the best way ahead for creating therapies for the illness.”

Within the research, the crew mixed two not too long ago developed laboratory assessments to quickly measure prions in human tissue samples: a brand new amyloid beta detection system and a tau prion assay.

Not like earlier animal fashions that would take months to disclose the gradual unfold of amyloid beta and/or tau prions, these cell-based assays measure infectious prion ranges in simply three days, enabling the researchers to successfully quantify for the primary time the degrees of each tau and amyloid beta prions in processed extracts from autopsy mind samples.

The scientists utilized the method to autopsied mind tissue from over 100 people who had died of Alzheimer’s illness and different types of neurodegeneration, which was collected from repositories in america, Europe, and Australia.

In assays evaluating the samples from Alzheimer’s sufferers with those that died of different illnesses, prion exercise corresponded precisely with the distinctive protein pathology that has been established in every illness: in 75 Alzheimer’s illness brains, each amyloid beta and tau prion exercise was elevated; in 11 samples from sufferers with cerebral amyloid angiopathy, solely amyloid beta prions had been seen; and in 10 tau-linked frontotemporal lobar degeneration samples, solely tau prions had been detected.

One other not too long ago developed bioassay for alpha-synuclein prions solely discovered these infectious particles within the seven samples from sufferers with the synuclein-linked degenerative dysfunction a number of system atrophy.

“These assays are a game-changer,” mentioned UCSF Professor William DeGrado, co-author of the research.

Probably the most outstanding discovering of the research was the invention that the self-propagating prion types of tau and amyloid beta are most infectious within the brains of Alzheimer’s sufferers who died at a younger age from inherited, genetically pushed types of the illness, however a lot much less prevalent in sufferers who died at a extra superior age.

Specifically, when in comparison with measurements of general tau buildup — which is understood to extend with age in Alzheimer’s brains — the research authors discovered a outstanding exponential decline within the relative abundance of the prion types of tau with age.

When the researchers plotted their information, they noticed a particularly robust correlation between tau prions and sufferers’ age at demise: relative to general tau ranges, the amount of tau prions within the mind of a affected person who died at age 40 had been on common 32 occasions greater than in a affected person who died at 90.

The research raises a variety of questions that can must be addressed by future research, together with whether or not variations in prion infectivity may clarify the long-standing thriller of why Alzheimer’s progresses at such completely different charges in several sufferers.

Different open questions embody whether or not greater prion ranges in mind samples from youthful sufferers are linked to the early onset of the illness or how shortly it progressed, and whether or not decrease prion ranges in older brains replicate much less ‘infective’ prion variants or as a substitute some capability of those sufferers’ brains to eliminate misfolded proteins.

“The proof that prion types of amyloid beta and tau play a selected function in Alzheimer’s illness additionally raises questions on present approaches to Alzheimer’s analysis, medical trial design, and drug discovery,” the scientists mentioned.

“We’ve not too long ago seen many seemingly promising Alzheimer’s therapies fail in medical trials, main some to invest that now we have been concentrating on the fallacious proteins,” Dr. Condello mentioned.

“However what if we simply haven’t been designing medication towards the distinctive prion types of these proteins that truly trigger illness? Now that we are able to successfully measure the prion types of amyloid beta and tau, there’s hope that we are able to develop medication that both stop them from forming or spreading, or assist the mind clear them earlier than they trigger harm.”

The research was printed within the journal Science Translational Medication.


Atsushi Aoyagi et al. 2019. Aβ and tau prion-like actions decline with longevity within the Alzheimer’s illness human mind. Science Translational Medication 11 (490): eaat8462; doi: 10.1126/scitranslmed.aat8462

Leave a Reply